ライフサイエンスコーパス: blood group O

1 Ninety-one percent of donors were blood group O.

2 an blood samples from adults and newborns of blood groups O, A, and B were treated with either anti-A

3 0.27-0.70) of type 2 diabetes compared with blood group O, adjusting for sE-selectin, sICAM-1, TNF-R

4 bited less human antibody binding than human blood group O allogeneic RBC in 22% of tested sera.

5 e 1998, we transplanted 15 A2 kidneys into 6 blood group O and 9 blood group B patients.

6 previously frozen plasma (four units each of blood group O and A), which can be issued immediately fo

7 f blood group A2 kidneys (20% of group A) to blood group O and B patients expands their potential don

8 the allocation of blood group A2 kidneys for blood group O and B recipients is a practical way to exp

9 nsplantation within 30 days for infants with blood group O and may benefit a broader range of transpl

10 is demonstrated that the association between blood group O and protection from infection with V. chol

11 is for understanding the association between blood group O and the risk of infection with V. cholerae

12 The three recipients had blood group O and were in the highest-risk waiting-list

13 risk factor for bleeding in combination with blood group O and/other unknown genetic factors, and (3)

14 rmediate rate (30%) among secretors with non-blood group O, and the highest rate (51%) among secretor

15 Individuals with blood group O are more susceptible than other individual

16 The mean wait time of blood group O cadaveric kidney wait list candidates incr

17 Blood group O candidates had higher 2-year mortality (26

18 The wait times of blood group O candidates will not be affected adversely

19 ison with the frameshift deletion underlying blood group O: case-control allelic odds ratio (OR), 1.2

20 Individuals of blood group O comprised 63.4% of patients, compared with

21 to the Globo H hexaglycosylceramide, i.e. a blood group O determinant on a type 4 core chain, the ge

22 abA-expressing H. pylori strains bind to the blood group O determinants on type 1 core chains, i.e. t

23 iver/small intestinal transplantation with a blood group O donor to a blood type A recipient is descr

24 ood group compatible donors, 100 consecutive blood group O donors, or ten highly selected homozygous

25 and measured with IgG essentially restricted blood group O donors.

26 ssociated with severe malaria, is reduced in blood group O erythrocytes compared with groups A, B, an

27 Patients with blood group O, female patients, older patients, and retr

28 th VWF:RCo < 50 U/dL (< 40 for patients with blood group O) fulfilled the acquired von Willebrand syn

29 VWF may still play a role in some cases and blood group O is common.

30 Blood group O is much more common in type 1 von Willebra

31 n the transplant team preferentially selects blood group O living donors and cadaveric kidney allocat

32 candidates will not be affected adversely if blood group O living donors are selected preferentially

33 We hypothesized that blood group O may confer resistance to severe falciparum

34 Compared with blood group O, non-O blood groups were associated with h

35 mic equivalents [gEq]) for secretor-positive blood group O or A persons and 7.0 (approximately 2800 g

36 Twenty-one persons were infected (all blood group O or A), and 67% of those infected developed

37 Blood group O patients who underwent transplantation wit

38 In blood group O patients, levels of anti-A antibodies were

39 or B patients had lower antibody levels than blood group O patients.

40 ferase-deficient enzyme that encodes the ABO blood group O phenotype previously proposed to protect a

41 were isolated from the small intestine of a blood group O pig and characterized by mass spectrometry

42 Blood group O piglets received kidney allografts from gr

43 el was associated with high SES, white race, blood group O, private insurance, and residence in regio

44 While blood group O protected significantly against infection

45 ransplantation of blood group A2 livers into blood group O recipients is safe and can be performed wi

46 ered more transplant opportunities to women, blood group O recipients, retransplants, and older patie

47 ped to avoid increasing the waiting time for blood group O recipients, we would support the implement

48 was significantly greater in volunteers with blood group O than those with non-O blood types (10,353

49 Previous ABO sensitization, donor blood group O to recipient blood group A or B transfer,

50 e samples were collected from a patient with blood group O undergoing antibody removal and subsequent

51 proposal would disadvantage cadaveric kidney blood group O wait list candidates, and present an appro

52 t exchanges is the potential to disadvantage blood group O wait list candidates.

53 made the novel observation that persons with blood group O were less likely than those with other blo

54 or studies, however, household contacts with blood group O were more likely to develop severe illness

55 with each group including 2 volunteers with blood group O, were given a dose of 10(5) CFU, and 34 of

56 ible adult patients (aged >/= 18 years) with blood group O+, who required up to two whole blood unit